Tus kws kho mob
Fabhalta (iptacopan) - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1111 - 1120 ntawm 3685
Tus kws kho mob
Fabhalta® (iptacopan) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 01, 2025
Tus kws kho mob
QP57-24 Commercial and MHCP Pharmacy Benefit Exclusion for Beqvez® and Hepzato™
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 10, 2024
Tus kws kho mob
QP55-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 10, 2024
Tus kws kho mob
QP56-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 10, 2024
Tus kws kho mob
P46-24 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2024
Tus kws kho mob
P47-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2024
Tus kws kho mob
P44-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Musculoskeletal Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2024
Tus kws kho mob
QP53-24 Claims Processing for Minnesota Health Care Programs
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 10, 2024
Tus kws kho mob
FEP Authorized Representative Designation Form